Ensoma ApS

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

CVR 40 80 43 07AnpartsselskabKøbenhavn ØStiftet 2019

S is engaged in the discovery and development of therapeutic gene editing products, based on the foundational science and intellectual property around structure and function of the CRISPR-associated protein Cas12a.